Syngene International in its fourth quarter performance reported that its revenue from operations was up 11% year─on─year to Rs. 1,037 crore compared corresponding quarter last year which was at Rs. 933 crore.
Syngene is an India-based CRO that offers services such as clinical development, drug discovery and product formulation for the pharmaceutical industry.